Masimo (MASI) Expected to Announce Earnings on Tuesday

Masimo (NASDAQ:MASI) will likely be posting its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Masimo to post earnings of $1.42 per share and revenue of $593.35 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Masimo Stock Performance

Shares of NASDAQ MASI opened at $169.96 on Friday. The firm has a fifty day moving average price of $172.78 and a 200-day moving average price of $152.03. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The stock has a market cap of $9.10 billion, a PE ratio of 117.21 and a beta of 1.02. Masimo has a 1 year low of $101.61 and a 1 year high of $184.51.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Raymond James increased their price objective on shares of Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research note on Friday, December 27th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Piper Sandler upped their target price on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Stifel Nicolaus restated a “buy” rating and set a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Finally, Wells Fargo & Company upped their target price on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Masimo currently has a consensus rating of “Moderate Buy” and an average target price of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.